Baolingbao BiologyLtd Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Baolingbao BiologyLtd ha un patrimonio netto totale di CN¥2.0B e un debito totale di CN¥363.5M, che porta il suo rapporto debito/patrimonio netto a 17.9%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥2.7B e CN¥642.1M. L'EBIT di Baolingbao BiologyLtd è CN¥109.4M rendendo il suo rapporto di copertura degli interessi 13.6. Ha liquidità e investimenti a breve termine pari a CN¥276.7M.

Informazioni chiave

17.9%

Rapporto debito/patrimonio netto

CN¥363.52m

Debito

Indice di copertura degli interessi	13.6x
Contanti	CN¥276.72m
Patrimonio netto	CN¥2.03b
Totale passività	CN¥642.07m
Totale attività	CN¥2.68b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues

Nov 05

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Oct 08

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Sep 30

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Jul 03

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Jun 07

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

May 06

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥855.8M ) di 002286 superano le sue passività a breve termine ( CN¥585.5M ).

Passività a lungo termine: Le attività a breve termine di 002286 ( CN¥855.8M ) superano le sue passività a lungo termine ( CN¥56.5M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 4.3% ) di 002286 è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di 002286 si è ridotto da 39.5% a 17.9% negli ultimi 5 anni.

Copertura del debito: Il debito di 002286 è ben coperto dal flusso di cassa operativo ( 48.2% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di 002286 sono ben coperti dall'EBIT ( 13.6 x copertura).

Baolingbao BiologyLtd Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues

New minor risk - Earnings quality

Third quarter 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.031 in 3Q 2023)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Baolingbao Biology Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 21%

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

New minor risk - Earnings quality

Second quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.041 in 2Q 2023)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Investor sentiment improves as stock rises 19%

Baolingbao Biology Co.,Ltd. to Report First Half, 2024 Results on Jul 31, 2024

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

High number of new directors

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

Baolingbao Biology Co.,Ltd. Approves Directorate Appointments

First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.05 in 1Q 2023)

Investor sentiment deteriorates as stock falls 19%

Baolingbao Biology Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2023, Payable on 08 March 2024

New minor risk - Earnings quality

Baolingbao Biology Co.,Ltd. Proposes Cash Dividend for 2023

Full year 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.36 in FY 2022)

Baolingbao Biology Co.,Ltd., Annual General Meeting, Feb 28, 2024

Investor sentiment deteriorates as stock falls 18%

Baolingbao Biology Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 07, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.057 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.041 (vs CN¥0.13 in 2Q 2022)

Investor sentiment improves as stock rises 17%

Baolingbao Biology Co.,Ltd. to Report First Half, 2023 Results on Aug 25, 2023

Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2022, Payable on 20 June 2023

Full year 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.55 in FY 2021)

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.27 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 2Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 2Q 2021)

Baolingbao Biology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 27, 2022

Baolingbao Biology Co.,Ltd. Announces Final Cash Dividend for the Year 2021

Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to CN¥17.55

High number of new and inexperienced directors

Price target decreased to CN¥17.55

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.03 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.079 in 2Q 2020)

Baolingbao Biology Co.,Ltd. Announces Cash Dividend of A Shares for the Year 2020, Payment Date on June 3, 2021

Baolingbao Biology Co.,Ltd. Approves Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.04 in 1Q 2020)

Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020

Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections

New 90-day low: CN¥9.17

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: CN¥10.52

Market pulls back on stock over the past week

Third quarter earnings released

New 90-day low: CN¥13.71

First half earnings released

New 90-day high - CN¥19.77

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane